Are severe asthma patients at higher risk of developing severe outcomes from COVID‐19?

One of the key concerns in asthma management during the novel coronavirus disease 2019 (COVID-19) pandemic is the fear for an increased risk of contracting the novel coronavirus or developing a severe course of COVID-19 in asthmatic patients, especially those receiving inhaled corticosteroids (ICS) or biological therapies.1, 2 Therefore, the study by Heffler et al3 to determine the incidence of COVID-19 among patients with severe asthma in Italy...